SELLAS Life Sciences Gr Q4 EPS $(0.25) Misses $(0.21) Estimate
SELLAS Life Sciences Gr Q4 EPS $(0.25) Misses $(0.21) Estimate
SELLAS Life Sciences Gr第四季度每股收益（0.25）未達到預期（0.21）美元
SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.21) by 19.05 percent. This is a 41.86 percent increase over losses of $(0.43) per share from the same period last year.
SELLAS Life Sciences Gr（納斯達克股票代碼：SLS）公佈的季度虧損爲每股0.25美元，比分析師普遍預期的0.21美元（0.21美元）低19.05％。與去年同期每股虧損0.43美元（0.43）相比，增長了41.86％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。